PEX26 Functions as a Metastasis Suppressor in Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Digestive Diseases and Sciences

• Publication date

  2023-11-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-023-08168-wPMID 37957408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination

  2020cited by this paper
• Computed Tomography–Determined Sarcopenia Is a Useful Imaging Biomarker for Predicting Postoperative Outcomes in Elderly Colorectal Cancer Patients

  2020cited by this paper
• Mutations and mechanisms of WNT pathway tumour suppressors in cancer

  2020cited by this paper
• Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and β-Catenin Stabilization

  2019cited by this paper
• Alteration of the tumor suppressor SARDH in sporadic colorectal cancer: A functional and transcriptome profiling‐based study

  2019cited by this paper
• Expanding the clinical and genetic spectrum of Heimler syndrome

  2019cited by this paper
• Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.

  2019cited by this paper
• New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

  2018cited by this paper
• MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.

  2018cited by this paper
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2018influential reference
• Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells.

  2018cited by this paper
• Gene expression differences among different MSI statuses in colorectal cancer

  2018cited by this paper
• WIPI1, BAG1, and PEX3 Autophagy-Related Genes Are Relevant Melanoma Markers

  2018cited by this paper
• Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study

  2018cited by this paper
• A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder

  2018cited by this paper
• Next‐generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read‐through, and PEX26 mutated in Heimler syndrome

  2017cited by this paper
• Epithelial–mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer

  2017cited by this paper
• FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer

  2017cited by this paper
• Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

  2017cited by this paper
• Upholding a role for EMT in pancreatic cancer metastasis

  2017cited by this paper
• Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis

  2017cited by this paper
• EMT: 2016.

  2016cited by this paper
• Peroxisome biogenesis disorders

  2016cited by this paper
• Epithelial–mesenchymal transition in tumor metastasis

  2016cited by this paper
• Peroxisome biogenesis and human peroxisome-deficiency disorders

  2016cited by this paper
• Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

  2015cited by this paper
• ATM Functions at the Peroxisome to Induce Pexophagy in Response to ROS

  2015cited by this paper
• N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.

  2015cited by this paper
• Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

  2015cited by this paper
• Metabolic functions of peroxisomes in health and disease.

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• Peroxisomes: a nexus for lipid metabolism and cellular signaling.

  2014cited by this paper
• Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transduction.

  2013cited by this paper
• EMT and dissemination precede pancreatic tumor formation.

  2012cited by this paper
• Genetics and molecular basis of human peroxisome biogenesis disorders.

  2012cited by this paper
• Role of peroxisomes in ROS/RNS-metabolism: implications for human disease.

  2012cited by this paper
• Early events in cell adhesion and polarity during epithelial-mesenchymal transition

  2012cited by this paper
• Peroxisomal Dysfunction in Inflammatory Childhood White Matter Disorders: An Unexpected Contributor to Neuropathology

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• EMT, the cytoskeleton, and cancer cell invasion

  2009cited by this paper
• Peroxisomal proliferation protects from beta-amyloid neurodegeneration.

  2005cited by this paper

• Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer

  2025cites this paper
• An Integrative Genomics Approach for the Discovery of Potential Clinically Actionable Diagnostic and Prognostic Biomarkers in Colorectal Cancer

  2025cites this paper
• Nomogram Based on A‐To‐I RNA Editing for Predicting Overall Survival in Patients With Breast Cancer

  2025cites this paper
• Identification of small molecule inhibitors of Trypanosoma PEX15– PEX6 interaction

  2025cites this paper